Two Sigma Advisers
DNTH icon

Two Sigma Advisers’s Dianthus Therapeutics DNTH Stock Holding History

Two Sigma Advisers’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,000
Closed -$907K – 612
2025
Q4 		$907K Buy
+22,000
New +$853K ﹤0.01% 1526
2023
Q3 		– Sell
-11,088
Closed -$134K – 2434
2023
Q2 		$134K Buy
11,088
+1,460
+15% +$16.6K ﹤0.01% 2169
2023
Q1 		$122K Sell
9,628
-6,028
-39% -$66.7K ﹤0.01% 2351
2022
Q4 		$98.9K Sell
15,656
-2,307
-13% -$40.8K ﹤0.01% 2299
2022
Q3 		$405K Sell
17,963
-5,181
-22% -$142K ﹤0.01% 1936
2022
Q2 		$444K Buy
23,144
+8,488
+58% +$210K ﹤0.01% 1972
2022
Q1 		$680K Buy
14,656
+1,293
+10% +$70.6K ﹤0.01% 1834
2021
Q4 		$947K Sell
13,363
-325
-2% -$32.7K ﹤0.01% 1581
2021
Q3 		$1.59M Buy
13,688
+788
+6% +$91.8K ﹤0.01% 1375
2021
Q2 		$2.02M Sell
12,900
-56
-0.4% -$10.3K 0.01% 1295
2021
Q1 		$2.45M Sell
12,956
-325
-2% -$54.7K 0.01% 1170
2020
Q4 		$1.67M Buy
13,281
+1,637
+14% +$186K ﹤0.01% 1347
2020
Q3 		$1.27M Buy
+11,644
New +$1.38M ﹤0.01% 1392

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers's DNTH Position: Q1 2026 in Review

Two Sigma Advisers sold out of Dianthus Therapeutics (DNTH) in Q1 2026, closing a stake of 22,000 shares — an estimated $907K sold.

Two Sigma Advisers first reported a position in DNTH in Q3 2020 and held it in 13 quarters. The position peaked at $2.45M in Q1 2021. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Two Sigma Advisers reported no remaining Dianthus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 22,000 Dianthus Therapeutics shares in Q1 2026, an estimated $907K.
  • Two Sigma Advisers first reported a position in Dianthus Therapeutics in Q3 2020 and held it in 13 quarters.
  • Two Sigma Advisers's Dianthus Therapeutics position peaked at $2.45M in Q1 2021.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.